Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model

Abstract

Erectile dysfunction (ED) is a cause of decreased quality of life in more than 70% of diabetic men. Vascular endothelial growth factor (VEGF) has shown to improve overall endothelial and smooth muscle cell dysfunction in models of ED. We describe a novel technique for nonviral, in vivo gene transfection of VEGF in the rat corpus cavernosum. Diabetic rats were transfected with DNA encoding a fusion VEGF/green fluorescent protein (GFP) complex and fluorescence microscopy was used to monitor the expression of VEGF–GFP fusion protein. Western blot and PCR analyses confirmed the expression of the GFP–VEGF fusion protein and mRNA. Functional studies using cavernous nerve stimulation revealed maximal intracavernous pressures (ICPs) of 63.1 mm Hg, and 30.7 mm Hg in the normal and diabetic control groups, respectively, and 47.4 mm Hg in VEGF–GFP-transfected diabetic group. Immunohistochemical analysis of the cavernosal tissue from transfected rats showed increased smooth muscle content compared with the diabetic control group. We show for the first time in our animal model that expression of the transfected VEGF in cavernosal tissue leads to an overall improvement of maximal ICP and smooth muscle content. On the basis of these results, it is tempting to speculate that our nonviral vector system offers an excellent system for gene delivery into cavernosal tissue, and that VEGF gene therapy using this system could be useful in improving erectile function in diabetic men.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Rogers RS, Graziottin TM, Lin CS, Lue TF . Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Imp Res 2003; 15: 26–37.

    Article  CAS  Google Scholar 

  2. Christ GJ, Day N, Santizo C, Sato Y, Zhao W, Sclafani T et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544–H1553.

    Article  CAS  PubMed  Google Scholar 

  3. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G . hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006; 17: 1165–1176.

    Article  CAS  PubMed  Google Scholar 

  4. Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003; 91: 691–696.

    Article  CAS  PubMed  Google Scholar 

  5. Bivalacqua TJ, Usta MF, Champion HC, Adams D, Namara DB, Abdel-Mageed AB et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003; 169: 1911–1917.

    Article  CAS  PubMed  Google Scholar 

  6. Shen ZJ, Wang H, Lu YL, Zhou XL, Chen SW, Chen ZD . Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat. BJU Int 2005; 95: 890–894.

    Article  CAS  PubMed  Google Scholar 

  7. Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577–1581.

    Article  CAS  PubMed  Google Scholar 

  8. Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 20–28.

    Article  CAS  PubMed  Google Scholar 

  9. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297–7301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lee M, Ryu JK, Oh SM, Lee E, Shin HY, Song SU et al. Water-soluble lipopolymer as a gene carrier to corpus cavernosum. Int J Imp Res 2005; 17: 326–334.

    Article  CAS  Google Scholar 

  11. Kichler A . Gene transfer with modified polyethylenimines. J Gene Med 2004; 6: S3–S10.

    Article  CAS  PubMed  Google Scholar 

  12. Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705–715.

    Article  CAS  PubMed  Google Scholar 

  13. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 2005; 173: 318–323.

    Article  CAS  PubMed  Google Scholar 

  14. Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N et al. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 2006; 341: 755–762.

    Article  CAS  PubMed  Google Scholar 

  15. Gerber HP, Dixit V, Ferrara N . Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–13316.

    Article  CAS  PubMed  Google Scholar 

  16. Nor JE, Christensen J, Mooney DJ, Polverini PJ . Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375–384.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Koul S, Johnson T, Meacham RB, Koul HK . Cloning and characterization of VEGF from LnCaP cells, a line of prostate cancer cells, LOCUS AY766116, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=54401694.

  18. Dall'Era JE, Koul S, Mills JN, Myers J, Meacham RB, Koul HK . In-vivo transfection of the rat corpus cavernosum using a non-viral, linear polyethylenimine gene delivery system: a novel application (abstract no.; 1004, AUA annual meeting, 2006, Atlanta).

  19. Ahn GJ, Sohn YS, Kang KK, Ahn BO, Kwon JW, Kang SK et al. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Imp Res 2005; 17: 134–141.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by UCDHSC SOM and the Department of Surgery AEF grant support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H K Koul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dall'Era, J., Meacham, R., Mills, J. et al. Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. Int J Impot Res 20, 307–314 (2008). https://doi.org/10.1038/ijir.2008.1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.1

Keywords

This article is cited by

Search

Quick links